Gemcitabine or Gemcitabine Plus Oxaliplatin in the First-Line Treatment of Patients With Advanced Transitional Cell Carcinoma of the Urothelium Unfit for Cisplatin-Based Chemotherapy: A Randomized Phase 2 Study of the French Genitourinary Tumor Group (GETUG V01)-Reference-Cited by-同舟云学术

Gemcitabine or Gemcitabine Plus Oxaliplatin in the First-Line Treatment of Patients With Advanced Transitional Cell Carcinoma of the Urothelium Unfit for Cisplatin-Based Chemotherapy: A Randomized Phase 2 Study of the French Genitourinary Tumor Group (GETUG V01)

Published:2011-12 Issue:6 Volume:60 Page:1251-1257
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Culine Stéphane,Fléchon Aude,Guillot Aline,Le Moulec Sylvestre,Pouessel Damien,Rolland Frédéric,Ravaud Alain,Houédé Nadine,Mignot Laurent,Joly Florence,Oudard Stéphane,Gourgou Sophie

Publisher

Elsevier BV

Subject

Urology

Reference20 articles.

1. A prospective randomized trial comparing MVAC and CISCA chemotherapy for patients with metastatic urothelial tumors;Logothetis;J Clin Oncol,1990

2. Long-term follow-up of a phase III intergroup study of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooperative group study;Saxman;J Clin Oncol,1997

3. Seven year update of an EORTC phase III trial of high-dose intensity M-VAC chemotherapy and G-CSF versus classic M-VAC in advanced urothelial tract tumours;Sternberg;Eur J Cancer,2006

4. Gemcitabine and cisplatin versus methotrexate, vinblastine, doxorubicin, and cisplatin in advanced or metastatic bladder cancer: results of a large, randomized, multinational, multicenter, phase III study;von der Maase;J Clin Oncol,2000

5. Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer;von der Maase;J Clin Oncol,2005

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adjuvant vs. progression-triggered treatment with gemcitabine in platinum-ineligible high-risk bladder cancer patients: Long-term follow-up of a randomized phase 3 trial;Urologic Oncology: Seminars and Original Investigations;2023-08

2. Systematic Literature Review (SLR) and Network Meta-Analysis (NMA) of First-Line Therapies (1L) for Locally Advanced/Metastatic Urothelial Carcinoma (la/mUC);Current Oncology;2023-03-26

3. Das metastasierte Urothelkarzinom – leitlinienorientierte Therapie und neue Optionen;Journal für Urologie und Urogynäkologie/Österreich;2022-11-22

4. Das metastasierte Urothelkarzinom – leitlinienorientierte Therapie und neue Optionen;Der Urologe;2022-01-28

5. Adverse events of different chemotherapy regimens in the first-line treatment of patients with advanced or metastatic urothelial cancer: A systematic review and network meta-analysis of randomized controlled trials;Seminars in Oncology;2021-06